Readystate Asset Management LP Monte Rosa Therapeutics, Inc. Transaction History
Readystate Asset Management LP
- $3 Trillion
- Q1 2025
A detailed history of Readystate Asset Management LP transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 287,000 shares of GLUE stock, worth $1.33 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
287,000Holding current value
$1.33 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding GLUE
# of Institutions
107Shares Held
53.4MCall Options Held
69.1KPut Options Held
22.4K-
Nea Management Company, LLC Timonium, MD7.69MShares$35.5 Million3.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.64MShares$30.7 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.66MShares$26.1 Million1.15% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$26.1 Million54.61% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$22.7 Million0.27% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $216M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...